Zepbound’s retail list price runs over $1,060 per month. Almost nobody should pay that. The right savings pathway — which depends entirely on your insurance status — can bring that to $25, $299, or $449 per month. This guide maps every legitimate route, what changed recently, and what most patients are never told.
These are the questions patients actually ask — including the ones most pharmacists and doctors don’t think to raise proactively.
Through LillyDirect — Eli Lilly’s own direct channel — the 2.5 mg starter dose runs $299/month and the 5 mg dose runs $399/month. For maintenance doses (7.5 mg through 15 mg), the Self Pay Journey Program locks pricing at $449/month flat, but only if you refill within 45 days of each delivery. Miss that window and you revert to standard LillyDirect pricing: $499 for 7.5 mg, $699 for 10 mg, and higher for 12.5 mg and 15 mg. The retail pharmacy cash price without any savings program runs $1,060 or more per month across all doses — which is why LillyDirect is almost always the right choice for self-pay patients. GoodRx coupons bring retail prices down modestly to roughly $950–$1,070 at most pharmacies, with Costco and Sam’s Club typically at the lower end — but LillyDirect vials at $299–$449/month are substantially cheaper for maintenance patients.
With commercial insurance that covers Zepbound and the Lilly Savings Card activated, the minimum is $25 per fill (Tier 1). The savings card covers up to approximately $469 per fill — meaning if your plan’s copay is $494, you pay $25. The card expires December 31, caps annual savings at $1,300, and allows up to 13 fills per calendar year. Important update for current cardholders: income verification is now required — households above $100,000 annually may no longer qualify. Re-verify your eligibility at zepbound.lilly.com/savings. If your plan covers Zepbound but your copay exceeds the card’s cap, you pay the difference above $469. If your plan does not cover Zepbound, Tier 2 pricing applies — roughly $650/month with the card, versus $1,060+ without. Prior authorization is required by over 90% of commercial plans — your doctor must document your BMI, weight-related conditions, and treatment history.
Yes — as of July 1, the Medicare GLP-1 Bridge program provides access to Zepbound at approximately $50/month for eligible Medicare Part D beneficiaries, running through December 31, 2027. BMI and clinical criteria apply (see Section 3 of this guide). Separately, if you have a documented moderate-to-severe obstructive sleep apnea diagnosis, Medicare Part D may cover Zepbound today through the OSA indication — this pathway has existed since Zepbound’s FDA sleep apnea approval in December 2024 and is separate from the weight management Bridge. These are two different coverage routes — your situation determines which applies. The Lilly Savings Card cannot be used by Medicare beneficiaries. LillyDirect at $299–$449/month remains the best self-pay fallback if you don’t qualify for the Bridge.
The Zepbound Self Pay Journey Program at $449/month for maintenance doses (7.5 mg through 15 mg) requires each refill to be initiated within 45 days of your previous delivery. If you let that window lapse, you revert to standard LillyDirect pricing — which is $499 for 7.5 mg, $699 for 10 mg, and higher for the top doses. That’s a jump of $50 to $250 per month for one missed deadline. The fix is simple: set a phone calendar reminder for day 30 after each fill. LillyDirect ships in 3–5 business days, so initiating the refill on day 30 leaves plenty of buffer. Patients who miss the window can re-enroll in the program — the discounted pricing resets at the next order.
No — not at meaningful scale. The FDA ended enforcement discretion for 503A compounding pharmacies in February 2025 and for 503B outsourcing facilities in March 2025, following the declaration that the tirzepatide shortage was resolved in October 2024. In May 2026, the FDA proposed removing tirzepatide from the 503B bulk drug substances list entirely. One narrow exception remains: a state-licensed 503A pharmacy can compound tirzepatide for an individual patient when a prescriber documents a specific clinical need that brand-name products cannot meet — but mass-produced compounded copies are no longer permitted. Any telehealth service currently advertising cheap compounded tirzepatide is operating in a legally precarious position. Verify the pharmacy’s 503A state license at nabp.pharmacy before ordering anything.
Significantly. Zepbound received FDA approval in December 2024 as the first and only prescription drug for moderate-to-severe obstructive sleep apnea in adults with obesity. That’s a completely separate FDA indication from weight management — meaning insurance plans that exclude weight loss drugs may still cover Zepbound when it’s prescribed for sleep apnea. This includes Medicare Part D, which covers the OSA indication today without waiting for any pilot program. If you have a documented sleep apnea diagnosis, ask your doctor to specify the OSA indication on the prescription. A sleep study confirming moderate-to-severe OSA is typically required for prior authorization. This pathway has been underutilized — many patients with both diagnoses have been paying out of pocket for months when they would have qualified for coverage.
For uninsured cash-pay patients, LillyDirect’s $299–$449/month for Zepbound vials is comparable to or cheaper than NovoCare’s self-pay pricing for semaglutide-based medications. For commercially insured patients, both drugs can reach $25/month with their respective manufacturer savings cards — price is effectively equal. Clinically, Zepbound produces more weight loss on average: tirzepatide (Zepbound’s active ingredient) generated approximately 20% body weight reduction in trials versus roughly 13–15% for semaglutide (Ozempic/Wegovy). Ozempic has FDA approval for cardiovascular risk reduction that Zepbound currently lacks, which is clinically relevant for patients with established heart disease. The choice between them is a medical decision — but on weight loss per dollar, Zepbound typically outperforms.
Among retail pharmacies without any savings program, Costco and Sam’s Club typically land at the lower end: roughly $1,020–$1,075/month for any dose. Walmart runs slightly higher at $1,060–$1,115, Kroger at $1,055–$1,120, and CVS/Walgreens/Target at $1,069–$1,135. GoodRx coupons at these pharmacies bring prices to roughly $950–$1,070, but Lilly’s contracts limit meaningful third-party discounting on branded GLP-1s. You don’t need a Costco membership to use their pharmacy. That said, all of these cash prices are dramatically higher than LillyDirect vials at $449/month for maintenance doses — retail pharmacies should only be your route if you prefer the prefilled pen format and cannot access LillyDirect for some reason.
Real out-of-pocket costs by situation — not list prices. The same drug in the same city can cost $25 or $1,060 depending entirely on which program you use.
| Patient Situation | Monthly Cost | Key Conditions | How to Access |
|---|---|---|---|
| Commercial insurance + Savings Card Lowest | $25/month (Tier 1) | Plan must cover Zepbound · income under $100K · not Medicare/Medicaid · 13 fills/year max | Activate at zepbound.lilly.com/savings · must have prior auth |
| Medicare GLP-1 Bridge New July 1 | ~$50/month | Part D enrollee · BMI ≥35 or BMI 27+ with qualifying condition · not OSA/diabetes patients | Call your Part D plan · doctor submits prior auth · runs through Dec 2027 |
| Medicare Part D — OSA Indication | Varies by plan tier | Confirmed OSA diagnosis · doctor prescribes for sleep apnea · plan formulary must include it | Call your Part D plan · request prior auth with OSA documentation |
| LillyDirect — Starter (2.5 mg) | $299/month | No insurance required · valid prescription needed · home delivery or Walmart pickup | lilly.com/lillydirect · Walmart pharmacy LillyDirect pickup |
| LillyDirect — 5 mg dose | $399/month | No insurance required · same 45-day refill rule doesn’t apply at this tier | lilly.com/lillydirect · Walmart pickup available |
| LillyDirect — Maintenance (7.5–15 mg) Best Self-Pay | $449/month flat | Refill within 45 days of prior delivery — miss window and price jumps to $499–$699+ | lilly.com/lillydirect · KwikPen also at participating retail pharmacies |
| Commercial insurance — plan doesn’t cover Zepbound + card Tier 2 | ~$650/month | Commercial insurance only · Savings Card Tier 2 reduces from $1,060 to ~$650 | Savings card at zepbound.lilly.com/savings · appeal prior auth denial |
| Costco/Sam’s Club — cash price | $1,020–$1,075/month | No membership needed for pharmacy · GoodRx coupon may save $10–$40 · pen format only | goodrx.com for current coupon · no Costco membership required |
| Full retail — no savings program Avoid | $1,060–$1,135/month | Nobody should pay this · always ask pharmacist about LillyDirect or savings card first | Ask: “Can you run this through LillyDirect pricing?” before paying |
Patients on the LillyDirect $449 maintenance program who miss a single refill window can face a cost jump of $50–$250 per month until they re-enroll. Set a calendar reminder for day 30 of each fill cycle. LillyDirect ships in 3–5 business days — initiating the order on day 30 gives you adequate buffer for processing and shipping. If you’ve already missed a window, you can re-enroll at the next order — contact LillyDirect directly at lilly.com/lillydirect for re-enrollment instructions.
There are four distinct coverage routes for Zepbound. Each has different eligibility rules, costs, and access steps. The wrong pathway for your situation can cost you hundreds per month.
Compounded tirzepatide was legally produced by hundreds of pharmacies during the 2022–2024 shortage. The FDA removed tirzepatide from the drug shortage list in October 2024. Enforcement discretion for 503A pharmacies ended February 18, 2025 and for 503B outsourcing facilities on March 19, 2025. In May 2026, the FDA proposed removing tirzepatide from the 503B bulk substances list entirely. Mass-produced compounded tirzepatide is not legally available in the United States today. A narrow 503A pathway exists for documented individual clinical needs, but this does not apply to general obesity or weight management. If a telehealth service is selling you compounded tirzepatide without a specific documented clinical justification, verify their 503A pharmacy license at nabp.pharmacy before ordering.
Stop before walking into any pharmacy. Setting up the right savings program before your first fill is the single most important step — the difference between $25 and $1,060 for the same prescription.
If you have commercial insurance: Go to zepbound.lilly.com/savings first. Activate the Savings Card, confirm your plan covers Zepbound, and confirm your income is under $100,000 annually. Bring the card to the pharmacy with your prior authorization number. If your plan hasn’t approved yet, use LillyDirect at $299/month as a bridge while the prior auth is pending — then switch to the card once approved.
If you have Medicare: Call your Part D plan and ask two things: (1) Do you participate in the Medicare GLP-1 Bridge for weight management? (2) Do you cover Zepbound for obstructive sleep apnea if I have that diagnosis? Answer yes to either opens a covered pathway. If neither applies, LillyDirect at $299–$449/month is your fallback.
If you have no insurance: Go to lilly.com/lillydirect, enter your prescription, and set up delivery or Walmart pharmacy pickup at $299/month for the starter dose. Do not fill at a retail pharmacy without a savings program first.
A denial is not final. The most common reversal strategies, in order of speed:
1. OSA angle (if you have sleep apnea): Ask your doctor to resubmit the prior authorization with the obstructive sleep apnea indication rather than weight management. Zepbound’s December 2024 FDA approval for OSA is a separate indication — plans that exclude weight drugs may cover it for sleep apnea. This is the fastest reversal for patients with both diagnoses.
2. Formal appeal with complete documentation: Your doctor resubmits with full BMI history, weight-related comorbidities (hypertension, Type 2 diabetes, high cholesterol), and documentation of prior weight loss attempts. Many denials are overturned on first appeal with thorough paperwork.
3. Step therapy waiver: Some plans require trying a different medication first. Your doctor can request a step therapy waiver citing clinical necessity — success rates are reasonable when the physician documents why Zepbound is the appropriate choice.
While any appeal is pending: Use LillyDirect at $299–$449/month to stay on medication. Do not miss doses while waiting — interruptions slow progress and may require restarting dose titration.
Medicare now has two separate coverage routes for Zepbound. Which one you use depends on your diagnosis:
For weight management (new July 1): The Medicare GLP-1 Bridge provides Zepbound at approximately $50/month for eligible Part D or MA-PD plan enrollees. You must meet BMI-based clinical criteria: BMI 35 or higher with no additional condition required; BMI 30–34.9 with heart failure, uncontrolled hypertension, or CKD stage 3a+; or BMI 27–29.9 with prediabetes, prior heart attack, prior stroke, or peripheral artery disease. Prior authorization is submitted by your doctor. The $50 copay does not count toward your annual Part D out-of-pocket cap. Runs through December 31, 2027.
For obstructive sleep apnea: Standard Part D may cover Zepbound today if your plan has it on formulary for the OSA indication. This coverage is permanent (no expiration date), copayments count toward your $2,100 annual cap, and Extra Help recipients may pay as little as $12.65/month. Check your plan’s formulary at Medicare.gov or call your plan directly.
The Lilly Savings Card cannot be used by Medicare patients. LillyDirect at $299–$449/month is the best self-pay fallback if you don’t qualify for either covered pathway.
The 45-day window only applies to the Self Pay Journey Program at $449/month for maintenance doses (7.5 mg and above). Starter doses (2.5 mg at $299 and 5 mg at $399) don’t have this requirement.
For maintenance patients: your 45-day clock starts from the delivery date of your previous shipment — not when you ordered it. LillyDirect ships in 3–5 business days. The safest approach is to initiate your refill on day 28–30. This gives you plenty of shipping buffer while keeping you well within the 45-day window.
If you’ve already missed the window: don’t panic. You revert to standard LillyDirect pricing for that refill cycle, but you can re-enroll in the Self Pay Journey Program at your next order. Contact LillyDirect at lilly.com/lillydirect or call (800) 545-5979 to confirm the re-enrollment process.
Practical tip: The day your LillyDirect shipment arrives, set a reminder on your phone for 30 days out labeled “Refill Zepbound — $449 window.” Treating this the same as a bill payment due date is the right mindset.
Same active ingredient, different FDA approvals, different insurance paths. Zepbound and Mounjaro both contain tirzepatide at identical doses — 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Clinically, they are the same drug. Mounjaro is FDA-approved for Type 2 diabetes. Zepbound is FDA-approved for chronic weight management and obstructive sleep apnea.
Which one to ask for depends entirely on your diagnosis and coverage situation. If you have Type 2 diabetes, Mounjaro may be the cleaner insurance path — it doesn’t face the weight-loss drug exclusion that complicates Zepbound coverage for many plans. If you have obesity without diabetes, Zepbound is the FDA-indicated product for weight management. If you have both obesity and sleep apnea, Zepbound’s OSA indication may be the strongest argument for coverage.
Because both medications are clinically identical, there’s no medical reason to prefer one — it’s purely an insurance and access question. Your doctor and insurer together determine which name appears on the prescription.
Call Lilly patient support at (800) 545-5979 before missing a single dose. Most patients who stop Zepbound abruptly regain weight within months, and blood sugar control may deteriorate for patients also managing prediabetes or Type 2 diabetes. The medical cost of stopping can significantly outweigh the financial cost of finding a cheaper access route.
If you have commercial insurance and are paying more than $25/month, verify whether you’ve activated the Savings Card correctly — most patients paying high copays haven’t used the card or haven’t accepted the current terms. If your savings card has hit its annual cap ($1,300), contact Lilly directly to ask about hardship options.
If cost is the issue and you’re not on LillyDirect yet, that switch can immediately drop your monthly cost to $299–$449 without any insurance involvement. If you’re already on LillyDirect, confirm you haven’t missed the 45-day refill window for the $449 maintenance rate.
For Medicare patients not yet on the Bridge program, your doctor may be able to submit prior authorization now — the $50/month Bridge rate launched July 1.
📍 Find Pharmacies & Weight Management Help Near You
Tap any button to find LillyDirect-participating pharmacies, weight management clinics, sleep apnea specialists, and Medicare counseling near your location. Always verify pricing with the pharmacy directly — programs update frequently.
📌 Always call ahead to confirm LillyDirect pricing availability and stock before traveling.
Resources: lilly.com/lillydirect ·
zepbound.lilly.com/savings ·
goodrx.com/zepbound ·
Medicare help: 1-877-839-2675 (SHIP)
-
1Know your insurance type before going to any pharmacy. Commercial insurance with a covered plan → activate the Lilly Savings Card at zepbound.lilly.com/savings before your first fill. Medicare → call your Part D plan about the GLP-1 Bridge or OSA coverage. No insurance → set up LillyDirect at lilly.com/lillydirect. The order matters — setting this up before walking in is the difference between $25 and $1,060 per month.
-
2If you have sleep apnea and obesity, ask your doctor to note the OSA diagnosis explicitly on the prescription. This unlocks Zepbound’s separate FDA approval for obstructive sleep apnea — including Medicare Part D coverage that weight management prescriptions cannot access. You need a documented sleep study result confirming moderate-to-severe OSA (typically AHI 15 or more events per hour).
-
3LillyDirect maintenance patients: set a refill reminder for day 30 after every delivery. The $449/month rate for 7.5–15 mg doses requires refilling within 45 days. Miss it and you revert to $499–$699+. Treat this like a bill payment due date — a phone calendar reminder takes ten seconds and can save you $50–$250 per month.
-
4If your insurance denies Zepbound, ask your doctor to appeal with complete documentation before accepting the denial. Most denials are based on incomplete prior authorization paperwork. A resubmission with full BMI history, comorbidity documentation, and prior weight loss attempts overturns a significant portion of denials. Use LillyDirect as a bridge while the appeal is processed — do not stop doses.
-
5If cost is forcing you toward stopping, call Lilly at (800) 545-5979 before missing a dose. Weight regain begins within months of stopping, and losing the progress you’ve built costs more — medically and financially — than finding a cheaper access route. Patient support can explore hardship options, re-enroll you in programs, and connect you to assistance resources that may not be on your radar.
Zepbound pricing, savings card terms, LillyDirect pricing, and Medicare coverage rules change frequently. All pricing information reflects publicly available data as of mid-2026 and may have changed. Verify current terms directly with Eli Lilly at zepbound.lilly.com/savings and lilly.com/lillydirect before ordering. Medicare coverage rules — including the GLP-1 Bridge program — are subject to regulatory change; verify with your Part D plan or a free SHIP counselor at 1-877-839-2675. Nothing in this guide constitutes medical or financial advice. Zepbound is a prescription medication — consult your healthcare provider before starting, stopping, or changing your dose.